All posts by imreal

The Golden Tool for Container Closure Integrity Testing, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

This is particularly relevant for certain sterile pharmaceutical products, including mRNA and live vaccines, gene therapies and products with active cells.

A pioneering webinar focusing on container closure integrity (CCI) in pharmaceutical products is set to take place. This highly informative session will delve into the critical role of headspace gas ingress methods in maintaining product stability and safety.

The webinar is titled “Headspace Gas Ingress Methods: The Golden Tool for Container Closure Integrity Testing” and will be presented by Dr. Derek Duncan, PhD, Director at Lighthouse Instruments. Dr. Duncan’s extensive experience in the field includes applications for process monitoring and finished product inspection, notably using headspace analysis for 100 percent container closure integrity testing.

Over the years, the context of container closure integrity has broadened. It is not only linked to maintaining sterility but also to preserving critical headspace gas conditions. This is particularly relevant for certain sterile pharmaceutical products, including mRNA and live vaccines, gene therapies and products with active cells. These require ultracold storage or cryogenic temperatures to maintain stability and/or activity. Studies have indicated that ultracold storage temperatures can pose risks to traditional pharmaceutical primary packaging systems, specifically the CCI of vial-rubber stopper combinations and pre-filled syringe systems traditionally used to fill sterile pharmaceutical products.

The webinar will explore traditional container closure integrity testing (CCIT) methods and the emerging use of laser-based headspace analysis, a deterministic method that is being regularly implemented as the ‘golden tool’ for generating robust science-based CCIT data for all types of sterile pharmaceutical products.

LIGHTHOUSE, a leading innovator in process monitoring and finished product inspection, is known for its cutting-edge applications including headspace analysis for container closure integrity testing. The company has joined forces with Xtalks to present this insightful webinar, sharing its expertise with the wider industry.

Mark your calendars for Tuesday, July 25, 2023, and tune in at 10am EDT (4pm CEST/EU-Central) for this free webinar on container closure integrity testing methods.

For more information, or to register for this event, visit Headspace Gas Ingress Methods: The Golden Tool for Container Closure Integrity Testing.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

From Gender Dysphoria to Gender Euphoria Using Minimally Invasive Facial Transformation


Non-surgical aesthetic treatments

The growing appeal and destigmatization of aesthetic medical treatments across all genders creates unique opportunities for clinicians to do their part in supporting transgender individuals on their lifelong journey of self-discovery and self-expression

From LGB to LGBTQIA+, there was an evolution within the Pride Revolution. The well-known acronym, whose letters represent self-affirming pride, equality, and inclusivity, has had its own journey of discovery toward its broader identity. For the lesbian and gay community in the 1960s and ’70s, the addition of the “B” for bisexual was considered controversial, as the bisexual movement was seen as a “half-step out of the closet” and only a stone’s throw away from heterosexuality. The “T” representing transsexuality was perceived as even farther afield from the formative goals of the gay and lesbian alliance.(1) However, in the fullness of time, the LGBTQIA+ movement has come to represent acceptance, freedom, and self-expression. The University of San Francisco Lesbian, Gay, Bisexual, and Transgender Resource Center describes the 21st-century PRIDE values as evoking — Professionalism, Respect, Integrity, Diversity, and Excellence — building a collaborative culture unified in its shared values and beliefs that helps to set expectations and drive decision-making that inspires action.(2) Cynthia Elliott, MD, owner and primary practitioner of Skinspirations, notes, “The growing appeal and destigmatization of aesthetic medical treatments across all genders creates unique opportunities for clinicians to do their part in supporting transgender individuals on their lifelong journey of self-discovery and self-expression.”

Recent data from a Pew Research Center survey indicates a remarkable shift in the percentage of transgender individuals in the United States across generations. Among adults under 30, 5.1% identify as trans or nonbinary, with 2.0% identifying as trans men or trans women and 3.0% considering themselves nonbinary (neither strictly a man nor a woman). The percentage drops to 1.6% for adults aged 30 to 49 and further down to 0.3% for those over 50.(3)

Individuals of all genders are learning that there are non-surgical aesthetic treatments to help them look as feminine, masculine, or androgynous as they prefer. While some individuals identify with traditional binary gender roles, others prefer to express themselves somewhere on the spectrum between feminine and masculine.(4)

At Skinspirations, increasingly popular gender-aligning facial aesthetic treatments include enhancing masculine features by crafting strong chins and chiseled jawlines with horizontal brows or feminizing faces by permanently erasing facial hair and creating higher cheekbones, fuller lips, and tapered chins. These transformations are possible using injectable treatments, laser hair removal, and non-surgical body contouring.

Dr. Elliott encourages her patients to communicate their goals candidly, adding, “I had a new patient who presented to me as a man; when I asked him what he’d like to change, he answered, ‘I want cheeks like yours.’ When I told him he would look very feminine if I gave him cheeks like mine, he answered, ‘Exactly.’ We both knew at that moment what his appearance goals were. Over the following months, we elevated his brows, tapered his chin with filler, and narrowed his jawline with Botox; one of my aestheticians even lent him a skirt. It was a gratifying project for all of us.”

About Dr. Cynthia Elliott and Skinspirations

Cynthia Elliott, M.D., is the owner and primary practitioner of Skinspirations, a cosmetic and regenerative medical practice that provides injectable and laser aesthetic treatments, professional skincare, body contouring, and regenerative treatments for aesthetic and musculoskeletal concerns. Located in Clearwater, Florida, Dr. Elliott is valued for her medical expertise and her training on the national level for the makers of Botox® Cosmetic and Juvéderm and internationally for Cutera Lasers. Her patients seek her expertise, knowing that she and her long-tenured staff have trained many professionals in the Tampa Bay area. Skinspirations has performed over 88,000 cosmetic medical treatments since 2005 and is known for the most effective aesthetic and regenerative medical treatments available, providing the quality results that other practitioners are still trying to learn. Dr. Elliott, whose medical training began in emergency medicine, currently serves as an expert witness in Cosmetic Medicine for the Florida Board of Medicine. For more information, visit http://www.skinspirations.com.

References:

1.Writer, S. (2017, March 6). It took us a long time to add the “t” to LGB. The Columbus Dispatch. dispatch.com/story/opinion/columns/2017/03/07/it-took-us-long-time/22014018007/.

2. Pride values. LGBT Resource Center. (n.d.). //lgbt.ucsf.edu/pride-values.

3. Brown, A. (2022, June 7). About 5% of young adults in the U.S. say their gender is different from their sex assigned at birth. Pew Research Center. pewresearch.org/short-reads/2022/06/07/about-5-of-young-adults-in-the-u-s-say-their-gender-is-different-from-their-sex-assigned-at-birth/.

4. De Boulle, K., Furuyama, N., Heydenrych, I., Keaney, T., Rivkin, A., Wong, V., Silberberg, M. (2021, May 13). Considerations for the use of minimally invasive aesthetic procedures for facial remodeling in transgender individuals. Clinical, cosmetic and investigational dermatology. ncbi.nlm.nih.gov/pmc/articles/PMC8128506/.

Share article on social media or email:

U.S. Dermatology Partners Celebrates Merger of Two North Dallas Locations, Creating Dallas’ Leading State-of-the-Art Integrated Care Center with Specialized Expertise


U.S. Dermatology Partners North Dallas

“Our new North Dallas office embodies our commitment to provide exceptional dermatological care to our patients with a team of the top physicians in the region under one roof to deliver unparalleled expertise and personalized treatments,” said Paul Singh, CEO of U.S. Dermatology Partners.

U.S. Dermatology Partners, one of the leading and largest dermatology groups in the country, announced a significant milestone with the opening of its new North Dallas location. The new office is the result of the merging of the organization’s two North Dallas locations, forming a specialized integrated care center led by seven highly trained providers who are experts in various fields of dermatology.

This state-of-the-art location, located within U.S. Dermatology Partners’ corporate headquarters at 5310 Harvest Hill in North Dallas, will feature board-certified dermatologists, a fellowship-trained Mohs surgeon, and a board-certified dermatopathologist, many of whom have earned prestigious recognition as Super Doctors®.

Together, these physicians will provide a wide variety of dermatologic services, including treatments for conditions such as skin cancer, psoriasis, eczema, and acne. They will also provide specialized treatments like Mohs micrographic surgery, and cosmetic services such as IPL laser treatments, Vivace skin-tightening, HydraFacial, PRP (platelet-rich plasma), microneedling for hair loss, laser hair removal, chemical peels, a line of medical grade skin care products, and more.

A wide range of dermatologic care under one roof is unique for Dallas County, making U.S. Dermatology Partners’ new location particularly convenient and innovative for patients requiring multiple types of care.

“Our new North Dallas office embodies our commitment to provide exceptional dermatological care to our patients. We have a team of the top physicians in the region who will collaborate under one roof to deliver unparalleled expertise and personalized treatments,” said Paul Singh, CEO of U.S. Dermatology Partners. “This office will strengthen our capacity to serve the Dallas community and allow us to remain at the forefront of innovative and comprehensive dermatological solutions nationally. We look forward to continuing our commitment to exceptional patient care, setting new standards for healthcare facilities with our state-of-the-art integrated care center.”

The providers at U.S. Dermatology Partners’ new North Dallas office include:

“The opening of our new North Dallas office is a truly significant milestone,” said Dr. Jay Wofford, board-certified dermatologist and regional president for the North Texas area at U.S. Dermatology Partners. “With unwavering dedication from our staff and leadership, we will be able to better serve our Dallas patients. Our North Dallas physicians bring a wealth of knowledge and innovative approaches to the practice, ensuring that our patients receive the most ethical and exceptional care experience possible. We look forward to serving our community and making a positive impact on the lives of our patients.”

The new location is located at 5310 Harvest Hill Rd. #130, Dallas, TX 75230, and is accepting patients now. Patients can request an appointment here.

U.S. Dermatology Partners is also proud to feature additional specialized care centers in Plano, Texas; Denver, Colorado; Leawood, Kansas; Lees Summit, Missouri; Phoenix, Arizona; and Tyler, Texas.

For more information, please visit http://www.usdermpartners.com.

Share article on social media or email:

Renowned Beverly Hills Oculoplastic Surgeon Dr. Kami Parsa Named a 2023 Top Patient Rated Doctor by Find Local Doctors


Dr. Kami Parsa

“My goal has always been to provide compassionate care and achieve natural results for my patients, offering the latest treatments available,” says Dr. Kami Parsa.

Dr. Kami Parsa, a highly-credentialed oculoplastic and reconstructive surgeon in Beverly Hills, has recently been recognized as a Top Patient Rated Doctor by Find Local Doctors. His patient-centered approach and expert knowledge in oculoplastic procedures have fostered a large volume of outstanding reviews from his patients across multiple online sources. Such superior ratings have led Find Local Doctors, a credible online directory of medical providers, to honor Dr. Kami Parsa with this award. Dr. Parsa is a skilled oculoplastic surgeon who is highly sought-after for his specialization in reconstructive, revisional and cosmetic surgery of the eyes and surrounding tissue. He is known for excellence in cosmetic eyelid surgery, upper eyelid lifts, and minimally-invasive surgical techniques. As a double-board-certified ophthalmologist and oculofacial plastic surgeon, Dr. Parsa is renowned for his artistic approach and meticulous attention to detail.

Over the course of his career, Dr. Kami Parsa has performed thousands of procedures to help patients achieve a refreshed and rejuvenated appearance. He is known across the country for his expertise and has earned numerous awards as a leading Beverly Hills oculoplastic surgeon, appearing on multiple media outlets, such as The Doctors, Botched, The New York Times and the Miami Herald. While Dr. Parsa holds elite qualifications and experience in his field, he passionately pursues new innovative techniques to produce beautiful results with minimal downtime for his patients. Offering cosmetic procedures such as blepharoplasty (eyelid lift) and eyebrow lifts, Dr. Parsa also performs a full menu of complex reconstructive surgeries for the eyes, including those involving ectropion repair, orbital decompression and Bell’s Palsy. In addition, at his Beverly Hills practice patients can take advantage of non-surgical treatments in facial rejuvenation using fillers, lasers, micro needling and more.

“My goal has always been to provide compassionate care and achieve natural results for my patients, offering the latest treatments available,” says Dr. Kami Parsa.

More about Dr. Kami Parsa:

Kami Parsa M.D. is a native of California. He attended UCLA and graduated with honors from the University of Southern California School of Medicine. Dr. Parsa completed a residency in ophthalmology at USC’s prestigious Doheny Eye Institute. He then finished a two-year sub-specialty fellowship in Oculoplastic & Reconstructive Surgery at the University of Miami’s Bascom Palmer Eye Institute. Dr. Parsa participates in several humanitarian efforts and is a member of the American Academy of Ophthalmology and fellowship trained by the American Society of Ophthalmic Plastic & Reconstructive Surgeons. He is also a clinical professor at USC’s Department of Ophthalmology and Department of Plastic Surgery and has published extensively in leading medical journals and textbooks. Dr. Parsa frequently lectures at major meetings and conferences around the world. For more information about the cosmetic and reconstructive services offered by Dr. Kami Parsa, please call his clinic located at 465 N Roxbury Dr. Suite 1011 in Beverly Hills, CA, at (310) 777-8880 or visit his website at http://www.oculoplastic.info.

Share article on social media or email:

Allegheny Health Network, Israel Innovation Authority Announce Plans for Technology Start-Up Collaboration


Allegheny Health Network, Israel Innovation Authority Announce Plans for Technology Start-Up Collaboration

“Health care is local, but health care research is global — and international partnerships are an important part of our targeted research strategy at AHN and Highmark Health,” said Keith Lejeune, AHN’s Senior Vice President for Research and Innovation.

Allegheny Health Network (AHN) and the Israel Innovation Authority announced today that they have signed a memorandum of understanding to establish a formal affiliation between AHN’s Research Institute and the Innovation Authority to support Israeli health-care startups, and provide them with access to AHN facilities for pilot projects, advanced technology support, and other forms of program assistance.

When launched, the organizations will collaborate on an array of technologies and business development opportunities that have the potential to bring some of Israel’s most promising health technology startups to Pittsburgh, giving the companies — and the entrepreneurs behind them — a local research partner and a foothold for American operations.

“We’re excited to partner with the Israel Innovation Authority to help cultivate some of their country’s brightest health care startups, and we’re thrilled to work with their entrepreneurs as they refine, test and scale innovative new technologies that may one day benefit patients and medical providers here in Pittsburgh, and around the world,” said Tariq J. Cheema, MD, medical director of the AHN Research Institute. AHN, based in Pittsburgh, Pennsylvania, is a 14-hospital health care organization and part of Highmark Health.

After the collaboration is finalized later this year, applications to the program will be opened in Israel, with the Innovation Authority and the AHN Research Institute jointly selecting, screening and approving finalists. The selected companies will then receive up to 50% funding from the Israel Innovation Authority for conducting joint research and development projects or pilots together with AHN.

The AHN Research Institute may also choose to supply its own seed funding, in addition to non-monetary support such as access to AHN facilities, consulting services, research assistance, information technology assistance, and clinical and administrative staff across a variety of clinical settings, for the purposes of piloting new technologies or even new drug therapies.

“The ability to develop a drug suitable for a particular population, to ensure its safety, and to prove its efficacy with precision, is paving the way for faster, smarter, and cost-effective medical care,” said Dr. Amiram Appelbaum, Chairman of the Israel Innovation Authority and Chief Innovation Scientist at the Ministry of Innovation, Science and Technology. “We are delighted to collaborate with an outstanding partner such as AHN, which has a rich legacy of advancing pioneering scientific research and groundbreaking clinical innovations that have improved the health and well-being of so many people over the decades.”

This collaboration will be part of the Innovation Authority’s larger International Health Centers R&D and Piloting program, which established similar partnerships with the Mayo Clinic, Hartford HealthCare and Thomas Jefferson University Hospitals in the U.S., as well as hospitals in the United Kingdom and Germany.

This new collaboration “will enable the Israeli medical innovation ecosystem to access top-tier facilities, know-how, infrastructure and expertise on a global scale, and provide Israeli companies with a new launchpad for their technologies and services,” Dr. Appelbaum said.

AHN, meanwhile, continues to expand its portfolio of partnerships with international collaborators. In recent months, AHN has formalized agreements with Splendo Health (Netherlands) and AdipoPharma (France) to share office space, lab space and professional resources at AHN Suburban, a former acute-care hospital in Bellevue, Pa., that is now being used as a health care innovation center.

AHN Suburban is also home to AlphaLab Health, a life-sciences incubator that was developed in partnership with Pittsburgh-based technology investor Innovation Works.

The AlphaLab Health incubator draws applicants from around the world to compete for pre-seed investment funding and participate in a mentorship program that helps them to navigate the key risk points in the clinical and commercial development of their early-stage companies.

“Health care is local, but health care research is global — and international partnerships are an important part of our targeted research strategy at AHN and Highmark Health,” said Keith Lejeune, AHN’s Senior Vice President for Research and Innovation. “These strategic alliances will be key as we work to nurture new health care technologies and companies that will help to solve the many systemic challenges that affect the U.S. and global health care systems.”

AHN’s partnership with the Innovation Authority is the latest in a series of collaborations between Pittsburgh-based innovators and their Israeli counterparts. For example, the group known as “412×972” — signifying the area code for Pittsburgh and the international calling code for Israel — has nurtured business connections between the two regions, and has helped dozens of Israeli and Pittsburgh companies partner on innovative projects since 2020.

AHN has been a participant in the 412×972 initiative from the beginning.

AHN Suburban is also home to Testa Seat, a company that builds adaptive seating for children and adults with special needs. Founded in Israel by Alex Geht, Testa Seat is part of AHN Suburban’s disability technology incubator program, and arrived in Pittsburgh through an Israeli initiative known as TOM — Tikkun Olam Makers.

TOM, a global nonprofit founded by Israeli entrepreneur Gidi Grinstein, sponsors companies that create affordable technologies and products for people living with disabilities, as well as the elderly and the poor. (Tikkun olam is the core Jewish concept of “repairing the world” through purposeful service and action.)

“Our agreement with the Israel Innovation Authority is the latest example of how AHN is seeking out partners locally and internationally who share our mission and values,” said Jeffrey Cohen, MD, Chief Physician Executive, Community Health and Innovation for AHN and leader of AHN Suburban. “Working together with the IIA, we can develop new technologies and solutions that further advance our Living Health strategy by helping marginalized populations, building stronger communities, and improving the lives of our patients and others around the world.”

###

About the Israel Innovation Authority

The Israel Innovation Authority, an independent publicly funded agency, was created to provide a variety of practical tools and funding platforms aimed at effectively addressing the dynamic and changing needs of the local and international innovation ecosystems. This includes early-stage entrepreneurs, mature companies developing new products or manufacturing processes, academic groups seeking to transfer their research developments to the market, global corporations interested in collaborating with Israeli technology, Israeli companies seeking new markets abroad and traditional factories and plants seeking to incorporate innovative and advanced manufacturing into their businesses. For more information, visit The Israel Innovation Authority | Israel Innovation (innovationisrael.org.il/en).

About the Allegheny Health Network

Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, an employed physician organization, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 22,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

IFCJ Announces Completion of 2023 Salary and Compensation Audit


Yael Eckstein: IFCJ Announces Completion of 2023 Salary and Compensation Audit

“At the International Fellowship of Christians and Jews, we take financial accountability and good stewardship of our donors’ funds very seriously.”

According to President and CEO Yael Eckstein, “the Salary and Compensation Audit reflects our ongoing commitment to take financial accountability and good stewardship of our donors’ funds very seriously.”

The International Fellowship of Christians and Jews (The Fellowship or IFCJ) recently announced the results of their annual Salary and Compensation Audit by Willis Towers Watson (WTW), a leading global advisory, broking, and solutions company. WTW provides employers reliable, relevant, and timely salary survey data combined with global, regional, and local HR and benefits policies and practices reports to support pay, employee benefits, and HR professionals in making the best decisions for their workforce and their organization.

IFCJ retained Willis Towers Watson to conduct a comparable market assessment of total remuneration (cash compensation plus benefits) provided to four executive-level positions, including the President and CEO, examining base salary and total cash compensation levels (base salary plus annual incentive awards).

The Salary and Compensation Audit confirmed management’s expectations that The Fellowship’s salary and compensation practices are fair, reasonable, and comparable to similar organizations.

“At the International Fellowship of Christians and Jews, we take financial accountability and good stewardship of our donors’ funds very seriously, and we ensure that salaries, including the salary of our President and CEO, Yael Eckstein, are fair within the nonprofit space and enable us to attract and retain the talent we need to best serve our community,” explained IFCJ Global Chief Operating Officer Robin Van Etten.

The market data used in this assessment included information that is:

Based on published and proprietary survey sources

Position specific, based on each position’s primary duties and responsibilities

Reflective of pay practices among nonprofit organizations for positions based in the U.S.

Size sensitive, based on IFCJ’s FY23 budgeted revenue

Updated to April 1, 2023, using an annualized adjustment factor of 3.5%, consistent with 2023 merit increase projections for non-profit executives

The International Fellowship of Christian and Jews‘ most recent financial information and audited statements are available either by written request or by contacting the organization’s Donor Services Department at (800) 486-8844.

About Yael Eckstein

As President and CEO of The Fellowship, Yael Eckstein oversees all programs and serves as the international spokesperson for the organization. With over a decade of nonprofit experience in multiple roles, Yael has the rare distinction of being a woman leading one of the world’s largest religious charitable organizations. In addition to her weekly podcast on matters of faith, Holy Land Reflections, Yael also invites thought leaders to discuss Jewish-Christian relations and Israel’s significance on her podcast, Conversations with Yael. She is the 2023 recipient of the Jerusalem Post’s Humanitarian Award, and in 2020 and 2021, was named to the publication’s list of 50 Most Influential Jews. Born outside of Chicago, Yael is now based in Israel with her husband and their four children.

About the International Fellowship of Christians and Jews

For 40 years, the International Fellowship of Christians and Jews has been leading efforts to build bridges between Christians and Jews and provide humanitarian care and lifesaving aid for Israel and the Jewish people. Through the generosity and loyalty each year of its donors, partners, and staff, The Fellowship helps over 1 million people living in poverty, has provided nearly 3,000 bomb shelters for security, and has helped 770,000 make aliyah back to their homeland, Israel. The Fellowship is celebrating its 40th anniversary this year, continuing a mission to bless Israel and the Jewish people – like our world has never seen.

Share article on social media or email:

Patina brings innovative primary care for people 65+ to Charlotte region; designed to help individuals thrive & remain independent


Patina Health

Designed specifically for older adults, Patina meets individuals on their terms through a convenient and highly personalized model that includes virtual care visits and in-home visits when needed.

Patina, a relationship-centered primary care provider dedicated to improving the healthcare and aging experience for people 65 and older, is expanding to serve members enrolled in participating Medicare Advantage plans across the Charlotte region beginning in July. Patina primary care is available at no extra cost to more than 100,000 people who participate in Aetna, Cigna Healthcare and UnitedHealthcare Medicare Advantage plans across the following 10 counties in North and South Carolina: Mecklenburg, Union, Gaston, Cabarrus, York, Chester, Lancaster, Lincoln, Iredell and Rowan counties.

Designed specifically for older adults, Patina meets individuals on their terms through a convenient and highly personalized model that includes virtual care visits and in-home visits when needed. This eliminates the need for patients to drive, park and wait for primary care appointments and makes Patina’s primary care experience accessible to anyone in the 10-county area.

“We’ve flipped the traditional primary care model on its head to give older adults the kind of primary care experience they deserve – one where they are truly seen and heard and, most importantly, have the opportunity to live their best lives and age independently at home,” says Patina CEO Jack Stoddard. “By taking a proactive approach that meets patients on their own terms, we get to really understand who they are and provide personalized care that’s aligned with their unique values, preferences and goals. We are excited to partner with leading health plans to serve new patients across the Charlotte area.”

Click here to hear Patina CEO Jack Stoddard describe Patina.

Every Patina patient is assigned a dedicated team that includes a primary care practitioner and Patina Health Champion, who serves as the go-to resource to help with legwork, navigating the complex healthcare system, coordinating care and connecting individuals to valuable community and health plan resources. Patina also makes it easy for patients’ family members and loved ones to participate in care planning and visits.

“Primary care should function as your partner, helping you to lead care for your total health, making sure your needs are met and that your values and preferences are followed over time,” says Neil Patel, M.D., Patina’s Chief Health Officer. “This is why Patina takes the time to build deep, trusted relationships with every patient we serve, so they can receive the dignity, empathy and care that they deserve.”

Click here to hear a real Patina patient describe their experience.

Charlotte area residents 65+ and their loved ones can learn more about Patina at patinahealth.com or 855.478.8310.

###

About Patina

Patina™ is reinventing primary care from the ground up to provide the healthcare and aging experience that older adults and their loved ones deserve. Each person we serve gets a dedicated care team built around them composed of primary care clinicians, a health champion and behavioral health and other specialists – all enabled by purpose-built technology and analytics. As a value-based primary care model, we are focused on delivering a high-quality, high-value experience to the people we serve.

Patina is a collaboration between two entities: The first is Patina Medical Group, P.C. (PMG-CAR), a virtual and home-based medical practice that provides clinical services to members of certain Medicare Advantage plans, and Patina Health, Inc., which provides administrative and management services to support PMG’s business operations and non-clinical quality assurance, as well as advanced information technology and products, population health analytics and thought leadership.

For more information about Patina visit https://patinahealth.com.

Media Contacts:

Charlotte

Kelsey Dixon

704.942.7248

kdixon@thebrandonagency.com

National

Aimee Eichelberger

312.952.1528

Aimee@superior.com

Share article on social media or email:

Validation of a Novel Head-Mounted Perimeter versus the Humphrey Field Analyzer


M&S Smart System® VR Headset

We are excited about the potential applications for this device and look forward to the M&S VR headset helping patients who otherwise could not or would not receive needed testing.

Researchers at the University of Iowa Carver College of Medicine and the Department of Ophthalmology and Visual Sciences recently completed a pilot study showing that a virtual reality headset can be used to reliably diagnose and monitor visual field loss in glaucoma patients. This study paves the way for wider adoption of such headsets, which will not only make testing quicker and more comfortable, but also more accessible for patients with mobility issues. This in turn would mean better screening and early detection of glaucoma in vulnerable parts of the population.

The study was conducted by two University of Iowa researchers who compared performance of a Smart System Virtual Reality Perimeter (SSVR) from M&S Technologies with a more traditional testing device, the Humphrey Field Analyzer (HFA). The HFA is a large device that does not allow for examination outside the clinic, and which “can be uncomfortable for patients with limited mobility or large body habitus.” Contrastingly, the SSVR is a head-mounted device that many users are already familiar with through other contexts, such as gaming.

The study looked at a population of adult patients diagnosed with glaucoma or suspected of having early glaucoma. Each patient completed visual field tests with both devices in a random order. Test results indicate that the SSVR was just as reliable as the HFA for testing purposes, especially as glaucoma severity increases. Test duration was also shorter in all cases, and the majority of participants tested said that they preferred the SSVR over the HFA when it came to the visual field testing experience.

“We were thrilled to learn not only that the headset performed well, but that patients preferred it,” says Mike Umali, National Sales Manager for M&S Technologies, makers of the Smart System and SSVR. “Whenever you can make testing more comfortable for patients while maintaining accuracy, it’s a win for everyone—doctors, patients, and device makers.”

The M&S SSVR is commercially available for use in visual field testing as well as numerous functional tests. M&S continues to evaluate new tests to determine which vision tests can be accurately adapted to the virtual reality headset platform.

“The goal is to equip practitioners with another tool they can use to help patients,” says Umali. “We are excited about the potential applications for this device and look forward to the M&S VR headset helping patients who otherwise could not or would not receive needed testing.”

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 6 million people worldwide blind due to the disease and another 13 million suffering from moderate to severe visual impairment. Many of the same studies that derive these estimates also show that glaucoma can be avoided with early detection and timely intervention.

About M&S Technologies: Founded in 1990, M&S Technologies is a software development and device manufacturer, rooted in state-of-the-art software development, local manufacturing, and superior customer service. M&S is known worldwide for leading technological advancements in visual testing systems. M&S is dedicated to bringing high quality, extremely accurate testing products to eye care professionals, optometry schools, and universities.

For more information, please visit http://www.mstech-eyes.com/vr-headset.

Share article on social media or email:

Doctor’s Say Most People Who Think They Are Allergic to Penicillin Are Likely Not


Allergist says that most who think they are allergic to penicillin are likely not and are limiting their access to medications.

“We now know that if someone has not been exposed to penicillin in over five years, there is about an 80% chance that the allergy is out of their system,” says Luis Saca, MD.

Many people think they’re allergic to penicillin, but experts say most of the population is not allergic at all. Allergist and immunologist Luis Saca, MD, implemented a new program at Loma Linda University Health to test for patients’ penicillin allergy and hopefully decrease the unnecessary use of broad-spectrum antibiotics.

According to the CDC, approximately 10% of U.S. patients report having a penicillin allergy. Realistically, however, fewer than 1% of the population is truly allergic to penicillin, as noted in the same CDC report. This allergy limits an individual’s access to many beneficial medications that are penicillin derivatives. Penicillin allergy patients must take broad-spectrum antibiotics that can increase healthcare costs and antibiotic resistance.

Saca says reactions to the drug in childhood cause many individuals to think they are allergic through adulthood. “The allergic reaction is not for life,” he says. “We now know that if someone has not been exposed to penicillin in over five years, there is about an 80% chance that the allergy is out of their system.”

Many patients also experience side effects and label it an allergy. Nausea, vomiting, and abdominal pain are just a few common side effects — not allergic reactions. Someone experiencing a true allergic reaction to penicillin may have a cough, shortness of breath, itchiness, or a rash. These are indicators of a type-1 hypersensitivity reaction in someone whose immune system developed an IgE antibody against a soluble antigen (eg., penicillin).

Saca says referrals to allergy and immunology will receive a progressive three-step test in one doctor’s visit.

1. Skin prick test. A positive reaction indicating an allergy will cause a red, itchy, raised bump. Patients with no reaction move to the next step.

2. Intradermal test. The faculty will then inject a small amount of solution under the skin of the forearm to create a small bump. Growth indicates a positive reaction. The patient will move to the final test if no growth is observed.

3. Oral test. Patients will receive amoxicillin in the office and are closely monitored by faculty for 45 to 60 minutes. Saca says if the first two tests are negative, the oral test is likely also negative.

Receiving negative results for all tests allows Saca to remove the penicillin allergy from the patient’s chart and restore their healthcare options.

To find out if your penicillin allergy is no longer in your system, make an appointment with your primary care doctor and ask for a referral to Allergy and Immunology. To schedule an interview with subject matter experts on this topic, please contact Molly Smith at mollysmith@llu.edu.

Share article on social media or email:

The American Med Spa Association Launches Multi-state Executive Legal Guides


“This product is designed to provide high-level but focused information for owners, investors and industry representatives who need information on medical spa compliance across several states,” says AmSpa CEO, Alex Thiersch, JD.

The American Medical Spa Association (AmSpa) has introduced its Multi-state Executive Legal Guides, a new resource designed to provide medical spa owners with practices in multiple states, and those who aspire to own practices in multiple states, with the most up-to-date information about the current legal landscape, as well as the unique legal issues they will encounter, in each state in which they operate.

Medical aesthetics is one of the fastest growing industries in the United States and, as successful medical spa owners continue to scale their businesses, they will no doubt encounter inconsistencies regarding the laws governing the industry from state to state. AmSpa’s Multi-state Executive Legal Guides are designed to help navigate these tricky waters with easy-to-understand and simple to consume information compiled by the association’s legal experts.

“We are very excited to launch AmSpa’s Multi-state Legal Guides, a new product that has been years in the making,” says AmSpa CEO, Alex Thiersch, JD. “This product is designed to provide high-level but focused information for owners, investors and industry representatives who need information on medical spa compliance across several states. We worked hard to provide easy and understandable access to the information you need to know to operate legally—who can perform treatments, ownership rules, legislation and regulation, and state-specific risk assessments. This tool is designed to give providers quick access to the basic information they need to operate legally in each state.”

Each Legal Guide includes three sections. First, the threat assessment provides a brief look at the relative restrictiveness of the state’s laws governing the medical aesthetics industry. Then, the compliance overview covers the state’s regulations regarding issues including ownership, supervision and delegation, scope of practice and more. Finally, the treatment delegation brief provides a look at whether and under what conditions practitioners are allowed to perform a wide variety of popular medical spa treatments. The legal guides are living documents that will be updated whenever new rules and regulations are enacted, and those who subscribe to the legal guides will also receive alerts when bills have been introduced or passed in the states in which they are subscribed.

“This product provides an easy-to-use solution for franchises, chains and other medical spas looking to expand into different states,” says AmSpa COO, Cathy Christensen. “Our hope is that with these simple guides, more medical spas will be able to operate safely and compliantly throughout the United States.”

The Multi-state Executive Legal Guides are available in three configurations: A single-state subscription, a regional subscription (Northeast, South, Midwest or West) and a national subscription. They do not require an AmSpa Membership to purchase.

“The Multi-state Executive Legal Guides represent the next iteration of this growing and exciting industry, and it’s only the beginning,” says Thiersch.

For more information about the Multi-state Executive Legal Guides, visit http://www.americanmedspa.org/med-spa-legal-guides. This webpage features pricing and additional information on what is included in each subscription.

—

About the American Med Spa Association (AmSpa)

The American Med Spa Association (AmSpa) provides business, legal and clinical training and resources to medical spas and aesthetic practices throughout the country. AmSpa’s events—including Medical Spa Boot Camps, Academy for Injection Anatomy trainings, Medical Spa Show and Women in Aesthetics Leadership Conference—provide business and legal best-practices to anyone entering the medical spa space or looking to improve their existing practice. AmSpa Members receive access to legal summaries of laws governing medical spas in their state, discounts, a robust and growing webinar library, and many other benefits. For more information visit http://www.americanmedspa.org, call 312-981-0993, or email info@americanmedspa.org.

Share article on social media or email: